Trials / Sponsors / Serpin Pharma, LLC
Serpin Pharma, LLC
Academic / Other · 3 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Terminated | SP16 as a Therapeutic for COVID-19 Induced ARDS SARS CoV 2 Infection, Pneumonia | Phase 1 | 2021-12-01 |
| Completed | SP16 Inflammatory Response Inhibition Trial Myocardial Infarction, Inflammation | Phase 1 / Phase 2 | 2020-02-24 |
| Completed | SP16 SERPIN-like Peptide Administration in Healthy Individuals Healthy Participants | Phase 1 | 2018-07-16 |